Total Payments
$271,640
2024 Payments
$10,851
Companies
27
Transactions
515
Medicare Patients
4,971
Medicare Billing
$547,062
Payment Breakdown by Category
Other$237,552 (87.5%)
Food & Beverage$14,047 (5.2%)
Travel$12,304 (4.5%)
Consulting$7,563 (2.8%)
Education$173.57 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $237,553 | 121 | 87.5% |
| Food and Beverage | $14,047 | 312 | 5.2% |
| Travel and Lodging | $12,304 | 58 | 4.5% |
| Consulting Fee | $7,563 | 10 | 2.8% |
| Education | $173.57 | 14 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $128,309 | 162 | $0 (2024) |
| Lilly USA, LLC | $57,261 | 75 | $0 (2024) |
| PFIZER INC. | $35,821 | 54 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $32,996 | 38 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $7,763 | 11 | $0 (2024) |
| Abbott Laboratories | $4,267 | 92 | $0 (2024) |
| Boston Scientific Corporation | $1,454 | 20 | $0 (2024) |
| Terumo Medical Corporation | $989.93 | 9 | $0 (2024) |
| Amgen Inc. | $561.16 | 16 | $0 (2023) |
| ABIOMED | $495.51 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,851 | 45 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,248) |
| 2023 | $36,584 | 77 | Boehringer Ingelheim Pharmaceuticals, Inc. ($27,485) |
| 2022 | $35,579 | 57 | Boehringer Ingelheim Pharmaceuticals, Inc. ($26,892) |
| 2021 | $48,873 | 58 | Boehringer Ingelheim Pharmaceuticals, Inc. ($30,740) |
| 2020 | $20,985 | 35 | Lilly USA, LLC ($10,634) |
| 2019 | $48,468 | 98 | Lilly USA, LLC ($20,539) |
| 2018 | $31,083 | 81 | E.R. Squibb & Sons, L.L.C. ($11,210) |
| 2017 | $39,216 | 64 | E.R. Squibb & Sons, L.L.C. ($21,661) |
All Payment Transactions
515 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | Boston Scientific Corporation | ROTAPRO (Device) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: ROTAPRO_IC | ||||||
| 09/17/2024 | CARDIVA MEDICAL, INC. | SAVVYWIRE (Device) | Food and Beverage | In-kind items and services | $57.81 | General |
| Category: DEVICES | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Obesity | ||||||
| 09/04/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $139.69 | General |
| Category: AVVIGO_IC | ||||||
| 09/04/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: General - Structural Heart_IC | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $36.97 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/09/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Vascular | ||||||
| 07/26/2024 | Terumo Medical Corporation | GLIDEWIRE (Device), HEARTRAIL, METACROSS OTW | Food and Beverage | In-kind items and services | $46.39 | General |
| Category: LESION ACCESS | ||||||
| 07/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: DIABETES | ||||||
| 07/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $37.52 | General |
| Category: DIABETES | ||||||
| 06/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: DIABETES | ||||||
| 06/24/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: DIABETES | ||||||
| 06/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $52.93 | General |
| Category: DIABETES | ||||||
| 06/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: DIABETES | ||||||
| 06/06/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,304 | 1,491 | $511,600 | $128,219 |
| 2022 | 24 | 1,164 | 1,440 | $524,933 | $135,167 |
| 2021 | 24 | 1,206 | 1,438 | $532,054 | $137,255 |
| 2020 | 26 | 1,297 | 1,409 | $621,161 | $146,421 |
Total Patients
4,971
Total Services
5,778
Medicare Billing
$547,062
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 57 | 64 | $112,192 | $25,819 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 265 | 296 | $45,584 | $25,380 | 55.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 118 | 118 | $133,222 | $20,115 | 15.1% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 36 | 36 | $50,857 | $8,999 | 17.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $18,870 | $8,591 | 45.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 66 | $14,784 | $8,294 | 56.1% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 20 | 20 | $24,940 | $4,898 | 19.6% |
| 93461 | Insertion of tube in right and left heart chambers, coronary artery, and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 16 | 16 | $24,448 | $4,252 | 17.4% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 47 | 48 | $13,968 | $3,429 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 44 | $4,312 | $2,357 | 54.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 40 | 107 | $13,268 | $2,240 | 16.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 190 | 192 | $8,256 | $1,845 | 22.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $3,900 | $1,807 | 46.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $3,861 | $1,754 | 45.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 28 | 30 | $4,410 | $1,736 | 39.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 156 | 159 | $13,833 | $1,666 | 12.0% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 40 | 106 | $12,508 | $1,616 | 12.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $2,769 | $1,314 | 47.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 19 | $1,995 | $1,169 | 58.6% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 23 | 23 | $1,702 | $463.45 | 27.2% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 18 | 18 | $1,224 | $329.22 | 26.9% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 16 | 17 | $697.00 | $144.48 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 235 | 272 | $41,888 | $24,076 | 57.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 44 | 51 | $89,403 | $21,377 | 23.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 110 | 111 | $125,319 | $20,746 | 16.6% |
About Dr. Jan Pattanayak, MD
Dr. Jan Pattanayak, MD is a Interventional Cardiology healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699860338.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jan Pattanayak, MD has received a total of $271,640 in payments from pharmaceutical and medical device companies, with $10,851 received in 2024. These payments were reported across 515 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($237,553).
As a Medicare-enrolled provider, Pattanayak has provided services to 4,971 Medicare beneficiaries, totaling 5,778 services with total Medicare billing of $547,062. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Asheville, NC
- Active Since 10/04/2006
- Last Updated 01/25/2022
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1699860338
Products in Payments
- JARDIANCE (Drug) $184,628
- ELIQUIS (Drug) $68,552
- XARELTO (Drug) $7,763
- OPTIS (Device) $2,140
- Optis Coronary Imaging System (Device) $689.78
- Repatha (Biological) $546.23
- Impella (Device) $495.51
- ROTABLATOR (Device) $390.98
- Xience V coronary stent system (Device) $316.32
- Xience Alpine cornary stent system (Device) $264.66
- AVVIGO Guidance System (Device) $254.91
- Navicross (Device) $234.70
- Xience Sierra Coronary Stent System (Device) $208.88
- GENERAL ATHERECTOMY (Device) $191.58
- PCI Optimization (Device) $188.21
- Diamondback Coronary (Device) $187.95
- SYMPLICITY G3 (Device) $153.27
- CROSSBOSS (Device) $146.82
- VYNDAQEL (Drug) $134.18
- Asahi Fielder coronary guide wire (Device) $132.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Asheville
Dr. John Lawrence, M.d, M.D
Interventional Cardiology — Payments: $231.65
Interventional Cardiology $231.65
Dr. William Maddox, M.d, M.D
Interventional Cardiology — Payments: $107.55
Interventional Cardiology $107.55
Dr. David Serfas, M.d, M.D
Interventional Cardiology — Payments: $75.90
Interventional Cardiology $75.90